|
|
Thursday, October 28, 2010 |
| |
I. Diagnostic and prognostic tools in haematological malignancies in 2010 |
|
| 08h30 - 09h00 |
Cytogenetic analysis |
S. Raynaud (Nice) |
| 09h00 - 09h30 |
Flow cytometry |
M.C. Béné (Nancy) |
| 09h30 - 10h00 |
Molecular biology: mutations, expression profiles, snp arrays |
S. Raynaud (Nice) |
| 10h00 - 10h30 |
Imaging techniques |
C. Haioun (Créteil) |
| 10h30 - 11h00 |
Coffee Break |
|
| |
II. Multiple myeloma and related disorders |
|
| 11h00 - 11h45 |
Prognostic factors and treatment of myeloma |
T. Facon (Lille) |
| 11h45 - 12h15 |
Macroglobulinemia, amyloidosis |
V. Leblond (Paris) |
| 12h15 - 12h45 |
Discussion and case reports |
|
| 12h45 - 14h20 |
Lunch |
|
| |
III. Lymphomas (Part I) |
|
| 14h20 - 15h00 |
Prognostic factors and treatment of adult aggressive lymphomas |
G. Salles (Lyon) |
| 15h00 - 15h30 |
Management of Hodgkin’s disease |
C. Ferme (Villejuif) |
| 15h30 - 16h00 |
Non hodgkin’s lymphoma in children |
C. Patte (Villejuif) |
| 16h00 - 16h30 |
- Discussion and case reports |
|
16h30 - 17h00 |
Coffee Break |
|
| |
IV. Chronic lymphoid leukaemia and related disorders |
|
| 17h00 - 17h30 |
Prognosis and treatment of CLL |
E. Monserrat (Barcelona) |
| 17h30 - 18h00 |
Discussion and case reports |
|
Friday, October 29, 2010 |
| |
V. Acute myeloid leukaemia |
|
| 09h00 - 09h20 |
Role of biology in the management of acute leukemias |
C. Preudhomme (Lille) |
| 09h20 - 09h50 |
Treatment of AML |
H. Dombret (Paris) |
| 09h50 - 10h20 |
APL and its treatment |
P. Fenaux (Bobigny) |
| 10h20 - 10h50 |
Discussion and case reports |
|
10h50 - 11h20 |
Coffee Break |
|
| |
VI. Acute lymphoblastic leukaemia |
|
| 11h20 - 11h50 |
Treatment of ALL in children |
A. Baruchel (Paris) |
| 11h50 - 12h20 |
Treatment of adult ALL |
H. Dombret (Paris) |
| 12h20 - 12h50 |
Discussion and case reports |
|
| 12h50 - 14h20 |
Lunch |
|
| |
VII. Myelodysplastic syndromes and related disorders |
|
| 14h20 - 14h50 |
Management of MDS |
P. Fenaux (Bobigny) |
| 14h50 - 15h20 |
Discussion and case reports |
|
| |
VIII. Chronic myeloid leukaemia |
|
| 15h20 - 15h50 |
Treatment of CML |
J. Goldman (London) |
| 15h50 - 16h10 |
Role of biology in the management of CML |
C. Preudhomme (Lille) |
| |
IX. Lymphomas (Part II) |
|
| 16h10 - 16h55 |
Prognostic factors and treatment of adult aggressive lymphomas |
A. Bosly (Yvoir) |
| 16h55 - 17h25 |
Discussion and case reports |
|
Saturday, October 30, 2010 |
| |
X. Myeloproliferative disorders (other than CML) |
|
| 08h30 - 09h00 |
Management of PV and ET |
J.J. Kiladjian (Bobigny) |
| 09h00 - 09h20 |
Idiopathic myelofibrosis |
F. Cervantes (Barcelona) |
| 09h20 - 09h50 |
Discussion and case reports |
|
09h50 - 10h20 |
Coffee Break |
|
| |
XI. Allogeneic stem cell transplantation |
|
| 10h20 - 10h50 |
Histocompatibility in allo SCT: familial and non familial donors |
N. Milpied (Nantes) |
| 10h50 - 11h20 |
Allogeneic SCT in myeloid malignancies |
N. Milpied (Nantes) |
| 11h20 - 11h40 |
Allogeneic SCT in lymphoid malignancies |
G. Salles (Lyon) |
| 11h40 - 12h10 |
Complications of allo SCT |
E. Gluckman (Paris) |
| 12h10 - 12h30 |
Cord blood transplantation |
E. Gluckman (Paris) |
| 12h30 - 13h00 |
Discussion and case reports |
|
| 13h00 - 14h30 |
Lunch |
|
| |
XII. Supportive care in haematological malignancies |
|
| 14h30 - 15h10 |
Management of infection in neutropenic patients |
J. Klatskersky (Bruxelles) |
| 15h10 - 15h40 |
Transfusion therapy |
Ph. Bierling (Créteil) |
| 15h40 - 16h10 |
Hematopoietic growth factors |
B. Meddeb (Tunis) |
| 16h40 |
End of the meeting |
|
| |
|
|
| |